Public Alert No. 09/2026 – Public Reminder of NAFDAC’s Regulatory Directive on the Discontinued Registration of Multi-Dose Artemether /Lumefantrine Dry Powder for Oral Suspension
The National Agency for Food and Drugs Administration and Control (NAFDAC) is reminding the public of the Regulatory Directive issued last year on the discontinued registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for Oral Suspension due to the instability of the reconstituted formulations, which results in the loss of efficacy of the suspension. See Public […]
